General Information of Drug Transporter (DT)
DT ID DTD0061 Transporter Info
Gene Name ABCC8
Transporter Name Sulfonylurea receptor 1
Gene ID
6833
UniProt ID
Q09428
Post-Translational Modification of This DT
Overview of ABCC8 Modification Sites with Functional and Structural Information
Sequence
MPLAFCGSEN HSAAYRVDQG VLNNGCFVDA LNVVPHVFLL FITFPILFIG WGSQSSKVHI 
HHSTWLHFPG HNLRWILTFM LLFVLVCEIA EGILSDGVTE SHHLHLYMPA GMAFMAAVTS 
VVYYHNIETS NFPKLLIALL VYWTLAFITK TIKFVKFLDH AIGFSQLRFC LTGLLVILYG 
MLLLVEVNVI RVRRYIFFKT PREVKPPEDL QDLGVRFLQP FVNLLSKGTY WWMNAFIKTA 
HKKPIDLRAI GKLPIAMRAL TNYQRLCEAF DAQVRKDIQG TQGARAIWQA LSHAFGRRLV 
LSSTFRILAD LLGFAGPLCI FGIVDHLGKE NDVFQPKTQF LGVYFVSSQE FLANAYVLAV 
LLFLALLLQR TFLQASYYVA IETGINLRGA IQTKIYNKIM HLSTSNLSMG EMTAGQICNL 
VAIDTNQLMW FFFLCPNLWA MPVQIIVGVI LLYYILGVSA LIGAAVIILL APVQYFVATK 
LSQAQRSTLE YSNERLKQTN EMLRGIKLLK LYAWENIFRT RVETTRRKEM TSLRAFAIYT 
SISIFMNTAI PIAAVLITFV GHVSFFKEAD FSPSVAFASL SLFHILVTPL FLLSSVVRST 
VKALVSVQKL SEFLSSAEIR EEQCAPHEPT PQGPASKYQA VPLRVVNRKR PAREDCRGLT 
GPLQSLVPSA DGDADNCCVQ IMGGYFTWTP DGIPTLSNIT IRIPRGQLTM IVGQVGCGKS 
SLLLAALGEM QKVSGAVFWS SLPDSEIGED PSPERETATD LDIRKRGPVA YASQKPWLLN 
ATVEENIIFE SPFNKQRYKM VIEACSLQPD IDILPHGDQT QIGERGINLS GGQRQRISVA 
RALYQHANVV FLDDPFSALD IHLSDHLMQA GILELLRDDK RTVVLVTHKL QYLPHADWII 
AMKDGTIQRE GTLKDFQRSE CQLFEHWKTL MNRQDQELEK ETVTERKATE PPQGLSRAMS 
SRDGLLQDEE EEEEEAAESE EDDNLSSMLH QRAEIPWRAC AKYLSSAGIL LLSLLVFSQL 
LKHMVLVAID YWLAKWTDSA LTLTPAARNC SLSQECTLDQ TVYAMVFTVL CSLGIVLCLV 
TSVTVEWTGL KVAKRLHRSL LNRIILAPMR FFETTPLGSI LNRFSSDCNT IDQHIPSTLE 
CLSRSTLLCV SALAVISYVT PVFLVALLPL AIVCYFIQKY FRVASRDLQQ LDDTTQLPLL 
SHFAETVEGL TTIRAFRYEA RFQQKLLEYT DSNNIASLFL TAANRWLEVR MEYIGACVVL 
IAAVTSISNS LHRELSAGLV GLGLTYALMV SNYLNWMVRN LADMELQLGA VKRIHGLLKT 
EAESYEGLLA PSLIPKNWPD QGKIQIQNLS VRYDSSLKPV LKHVNALIAP GQKIGICGRT 
GSGKSSFSLA FFRMVDTFEG HIIIDGIDIA KLPLHTLRSR LSIILQDPVL FSGTIRFNLD 
PERKCSDSTL WEALEIAQLK LVVKALPGGL DAIITEGGEN FSQGQRQLFC LARAFVRKTS 
IFIMDEATAS IDMATENILQ KVVMTAFADR TVVTIAHRVH TILSADLVIV LKRGAILEFD 
KPEKLLSRKD SVFASFVRAD K
PTM type
X-N-glycosylation X-Oxidation X-Phosphorylation X: Amino Acid

N-glycosylation

  Asparagine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence ABCC8 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

10

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at ABCC8 Asparagine 10 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence ABCC8 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

1049

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at ABCC8 Asparagine 1049 has the potential to affect its expression or activity.

Oxidation

  Cystine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence ABCC8 [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

717

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at ABCC8 Cystine 717 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence ABCC8 [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

921

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at ABCC8 Cystine 921 has the potential to affect its expression or activity.

Phosphorylation

  Serine

        12 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence ABCC8 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

165

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC8 Serine 165 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence ABCC8 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

302

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC8 Serine 302 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence ABCC8 [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

611

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC8 Serine 611 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence ABCC8 [1]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

720

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC8 Serine 720 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence ABCC8 [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

979

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC8 Serine 979 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence ABCC8 [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

986

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC8 Serine 986 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence ABCC8 [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

987

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC8 Serine 987 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence ABCC8 [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1324

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC8 Serine 1324 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence ABCC8 [1]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1355

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC8 Serine 1355 has the potential to affect its expression or activity.

  PTM Phenomenon 10

Have the potential to influence ABCC8 [1]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1356

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC8 Serine 1356 has the potential to affect its expression or activity.

  PTM Phenomenon 11

Have the potential to influence ABCC8 [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1500

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC8 Serine 1500 has the potential to affect its expression or activity.

  PTM Phenomenon 12

Have the potential to influence ABCC8 [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1510

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC8 Serine 1510 has the potential to affect its expression or activity.

  Threonine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence ABCC8 [9]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

912

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC8 Threonine 912 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence ABCC8 [1]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

949

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC8 Threonine 949 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence ABCC8 [7]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1320

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC8 Threonine 1320 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence ABCC8 [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1499

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC8 Threonine 1499 has the potential to affect its expression or activity.

  Tyrosine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence ABCC8 [10]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

798

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC8 Tyrosine 798 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence ABCC8 [7]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

1325

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC8 Tyrosine 1325 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence ABCC8 [1]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

1353

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC8 Tyrosine 1353 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: ABCC8_HUMAN)
2 A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
3 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
4 Phosphoproteome dynamics in onset and maintenance of oncogene-induced senescence. Mol Cell Proteomics. 2014 Aug;13(8):2089-100.
5 Comparison of SILAC and mTRAQ quantification for phosphoproteomics on a quadrupole orbitrap mass spectrometer. J Proteome Res. 2013 Sep 6;12(9):4089-100.
6 Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1. EMBO J. 2015 Nov 12;34(22):2840-61.
7 Phosphoproteome Analysis Reveals Differential Mode of Action of Sorafenib in Wildtype and Mutated FLT3 Acute Myeloid Leukemia (AML) Cells. Mol Cell Proteomics. 2017 Jul;16(7):1365-1376.
8 iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
9 Offline pentafluorophenyl (PFP)-RP prefractionation as an alternative to high-pH RP for comprehensive LC-MS/MS proteomics and phosphoproteomics. Anal Bioanal Chem. 2017 Jul;409(19):4615-4625.
10 A comparative study of flurbiprofen and indomethacin in rheumatoid arthritis. Curr Med Res Opin. 1977;5(1):64-73.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.